Troponin T in the first 24 hours after the administration of chemotherapy and the detection of myocardial damage in children

被引:33
作者
Kremer, LCM
Bastiaansen, BAJ
Offringa, M
Lam, J
van Straalen, JP
de Winter, RJ
Voûte, PA
机构
[1] Univ Amsterdam, Acad Med Ctr, Emma Kinder Ziekenhuis, Dept Pediat Oncol, NL-1105 AZ Amsterdam, Netherlands
[2] Univ Amsterdam, Acad Med Ctr, Emma Kinder Ziekenhuis, Dept Gen Pediat, NL-1105 AZ Amsterdam, Netherlands
[3] Univ Amsterdam, Acad Med Ctr, Emma Kinder Ziekenhuis, Dept Pediat Cardiol, NL-1105 AZ Amsterdam, Netherlands
[4] Univ Amsterdam, Acad Med Ctr, Emma Kinder Ziekenhuis, Dept Clin Chem, NL-1105 AZ Amsterdam, Netherlands
[5] Univ Amsterdam, Acad Med Ctr, Emma Kinder Ziekenhuis, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands
关键词
anthracyclines; cardiotoxicity; diagnosis; troponin T; children;
D O I
10.1016/S0959-8049(01)00431-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Early detection of damage to cardiac myocytes after cardiotoxic chemotherapy in paediatric patients may allow timely preventive measures to be taken. We investigated the diagnostic value of cardiac troponin T (cTnT) after the administration of cardiotoxic chemotherapy. In 38 children, cTnT levels were measured at three time points during the first 24 h after 58 cardiotoxic chemotherapy cycles (163 samples). An abnormal cTnT level, defined as a cTnT > 0.010 ng/ml, was measured in only six samples from 3 patients. After completion of chemotherapy, 7 out of the 38 patients had left ventricular dysfunction (LV dysfunction). Only 1 of these 7 patients had an elevated cTnT level. 2 other patients with elevated cTnT levels did not develop LV dysfunction until 2 and 7 months after the cTnT measurement. Our data show that the measurement of cTnT within 24 h after administration of chemotherapy does not have a high sensitivity for the identification of patients with subsequent subclinical cardiotoxicity. (C) 2002 Published by Elsevier Science Ltd.
引用
收藏
页码:686 / 689
页数:4
相关论文
共 18 条
[1]   Troponins in prediction of cardiotoxic effects [J].
Auner, HW ;
Tinchon, C ;
Quehenberger, F ;
Linkesch, W ;
Sill, H .
LANCET, 2001, 357 (9258) :808-808
[2]   Early identification of anthracycline cardiomyopathy: Possibilities and implications [J].
BuLock, FA ;
Mott, MG ;
Oakhill, A ;
Martin, RP .
ARCHIVES OF DISEASE IN CHILDHOOD, 1996, 75 (05) :416-422
[3]   Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy [J].
Cardinale, D ;
Sandri, MT ;
Martinoni, A ;
Tricca, A ;
Civelli, M ;
Lamantia, G ;
Cinieri, S ;
Martinelli, G ;
Cipolla, CM ;
Fiorentini, C .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 36 (02) :517-522
[4]   VALUE OF MYOGLOBIN, TROPONIN-T, AND CK-MB(MASS) IN RULING OUT AN ACUTE MYOCARDIAL-INFARCTION IN THE EMERGENCY ROOM [J].
DEWINTER, RJ ;
KOSTER, RW ;
STURK, A ;
SANDERS, GT .
CIRCULATION, 1995, 92 (12) :3401-3407
[5]  
Hallermayer K, 1999, SCAND J CLIN LAB INV, V59, P128
[6]   Correlation between serum levels of cardiac troponin-T and the severity of the chronic cardiomyopathy induced by doxorubicin [J].
Herman, EH ;
Zhang, J ;
Lipshultz, SE ;
Rifai, N ;
Chadwick, D ;
Takeda, K ;
Yu, ZX ;
Ferrans, VJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :2237-2243
[7]  
Kaplan S, 1997, CIRCULATION, V96, P2496
[8]   INTRACELLULAR COMPARTMENTATION OF CARDIAC TROPONIN-T AND ITS RELEASE KINETICS IN PATIENTS WITH REPERFUSED AND NONREPERFUSED MYOCARDIAL-INFARCTION [J].
KATUS, HA ;
REMPPIS, A ;
SCHEFFOLD, T ;
DIEDERICH, KW ;
KUEBLER, W .
AMERICAN JOURNAL OF CARDIOLOGY, 1991, 67 (16) :1360-1367
[9]   Anthracycline-induced clinical heart failure in a cohort of 607 children:: Long-term follow-up study [J].
Kremer, LCM ;
van Dalen, EC ;
Offringa, M ;
Ottenkamp, J ;
Voûte, PA .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (01) :191-196
[10]  
LIPSCHULTZ SE, 1998, P ASCO, pA568